Anders Sigvard Bjartell
Founder at Glactone Pharma AB
Profile
Anders Sigvard Bjartell is the founder of Glactone Pharma AB, which was founded in 2012.
He is currently a Professor at the University of Lund and the Chief Urology Officer & Professor at Skane University Hospital.
He previously worked as a Director at LIDDS AB from 2015 to 2022.
Dr. Bjartell obtained a doctorate degree from the University of Lund.
Anders Sigvard Bjartell active positions
| Companies | Position | Start |
|---|---|---|
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Founder | 2011-12-31 |
Skane University Hospital
 Skane University Hospital Hospital/Nursing ManagementHealth Services Skane University Hospital operates a search service called Hitta Vård, which provides contact information for public and private healthcare providers in the Skåne region of Sweden. The private company is based in Malmö, Sweden. The service is financed by Region Skåne. | Corporate Officer/Principal | - |
| University of Lund | Corporate Officer/Principal | - |
Former positions of Anders Sigvard Bjartell
| Companies | Position | End |
|---|---|---|
| LIDDS AB | Director/Board Member | 2022-05-01 |
Training of Anders Sigvard Bjartell
| University of Lund | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LIDDS AB | Health Technology |
| Private companies | 2 |
|---|---|
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Health Technology |
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Skane University Hospital operates a search service called Hitta Vård, which provides contact information for public and private healthcare providers in the Skåne region of Sweden. The private company is based in Malmö, Sweden. The service is financed by Region Skåne. | Health Services |
- Stock Market
- Insiders
- Anders Sigvard Bjartell
